TAMPA, FL / ACCESSWIRE / December 4, 2024 / BioFuse Medical Technologies proudly announces the appointment of Rick Earley as its new Chief Executive Officer. Rick, a serial and successful entrepreneur, brings a wealth of leadership experience to the company as it advances its groundbreaking Tissue Welding platform. Alongside Rick's appointment, BioFuse is also pleased to welcome four distinguished professionals to its advisory team, expanding the company's expertise in software and technology, manufacturing, regulatory affairs, and commercialization.
Rick Earley - Chief Executive Officer
Rick Earley is a seasoned entrepreneur and business leader with decades of experience building and scaling innovative companies across multiple industries, including manufacturing, automotive, and packaging. Rick founded MetPro Group, a global technology company focused on corrosion protection packaging for the automotive and steel industries, Rick led MetPro for nearly two decades prior to its sale a private equity firm, the Jordan Company (Transcendia). Rick was also co-owner of Floeter Inc, which was acquired by Prudential. (Ampac) Since then, Rick also founded Cirtex Ltd, one of Ireland's leading circular economy companies specializing in upcycling textiles and more recently, has expanded into the UK with the creation of Circomatt Ltd.
Rick's proven track record of creating sustainable, high-growth business models will guide BioFuse through its next phase of innovation. As CEO, and lead investor, Rick's leadership will be instrumental in advancing BioFuse's flagship tissue welding platform, poised to revolutionize the surgical closure industry by enhancing patient outcomes, reducing recovery times, and addressing critical healthcare cost challenges.
Dr. David Battleman, who has served as CEO of BioFuse Medical Technologies, is transitioning out of his role. During his tenure, Dr. Battleman played a pivotal role in advancing the company's groundbreaking tissue welding platform and establishing BioFuse as a leader in surgical innovation.
"We are grateful to David for his leadership and contributions as CEO," said Dr. Joseph Stauffer, Chairman of the Board of BioFuse Medical Technologies. "His vision and dedication have laid a solid foundation for BioFuse's future success."
JP Palacio - Software and Technology Advisor
JP Palacio serves as the CEO of Kromeon, a leading provider of custom software, mobile app development, and digital platform solutions tailored for startups and scaling businesses. Under his leadership, Kromeon has partnered with high-profile clients such as the NFL, Nordstrom, Domino's, and Dexcom, delivering cutting-edge technology solutions that blend innovation with functionality.
With a robust background in the med tech industry and a proven track record of managing complex, cross-industry projects, JP is recognized for his strategic vision and entrepreneurial approach. His expertise lies in developing user-centric solutions that not only meet business objectives but also promote long-term scalability and growth. JP's dedication to innovation and excellence consistently drives impactful results in every project he undertakes.
Edwin Aguilera - Product Development and Manufacturing Advisor
Edwin Aguilera is the founder of Nikao, Inc., a company recognized for its leadership in product design, development, and manufacturing. Nikao, founded in 2000, develops innovative medical devices and technologies that enhance the quality of life for individuals worldwide.
One of Nikao's breakthrough technologies is the Neural-Enabled Prosthesis (NEP) system in collaboration with Florida International University. NEP revolutionizes prosthetic functionality by simulating the sense of touch and feel for users of prosthetic hands. His diverse experience spans from neural-enabled prosthetics to cancer detection devices. Previously, he held senior leadership roles overseeing engineering, product development, manufacturing strategies, global distribution, and business development, showcasing his ability to scale operations effectively. His expertise will be instrumental as BioFuse advances the development of its MTF platform-an innovative suite of surgical devices poised to impact the multi-billion-dollar surgical closure industry.
Tariq Khurshid - Regulatory Advisor
Tariq Khurshid brings over 40 years of multidisciplinary and regulatory affairs experience, specializing in medical devices, pharmaceuticals, and combination products. He has held key positions at industry leaders such as Medtronic, Boston Scientific Corporation, Zimmer Biomet Inc., and Novartis (Alcon Vision Care).
Tariq has successfully managed premarket submissions, including 510(k) and PMA applications, ensuring compliance with FDA, EU MDR, and ISO standards. His leadership in developing risk management frameworks and implementing Quality Management Systems has helped organizations meet stringent regulatory requirements and secure global market approvals. Tariq's extensive background ensures BioFuse remains both focused and compliant while achieving key regulatory milestones.
Tim Schmitt - Commercial Advisor
Tim Schmitt, a U.S. Air Force veteran, has over 25 years of experience in the orthopedic and medical industries. After serving as an Air Force Medic, Tim built a distinguished career at Stryker Orthopedics, where he excelled in sales and regional leadership. Known for his deep product knowledge and ability to market advanced medical technologies, Tim trained surgeons and operating room staff on innovative procedures and equipment, establishing himself as a trusted expert in the operating room.
Tim contributed to the development and adoption of groundbreaking orthopedic solutions, including advancements in hip replacements and robotic knee replacement technologies. In 2019, he broadened his expertise by earning securities licenses and joining Great Point Capital as a registered representative.
With extensive experience in surgical environments, product innovation, and strategic marketing, Tim brings invaluable insights to BioFuse Medical Technologies as a Commercial Advisor.
"We are excited to welcome Rick Earley as our new CEO, alongside JP, Edwin, Tariq, and Tim on our advisory team," said Dr. Joseph Stauffer, Chairman of the Board of BioFuse Medical Technologies. "Rick's entrepreneurial vision and proven leadership, combined with our exceptional team of Advisors, will help propel BioFuse's innovative tissue welding platform toward widespread adoption, revolutionizing surgical procedures and improving healthcare outcomes worldwide."
About BioFuse Medical Technologies
BioFuse Medical Technologies, located in Tampa, Florida, is a developer of radio frequency (RF) technology for a variety of surgical procedures. The company's flagship product, the BioFuse Tissue Welding platform, leverages its proprietary high-frequency technology and is engineered to surpass the performance of traditional sutures and staples, enhancing patient outcomes and reducing healthcare costs. With a $3+ billion market potential, BioFuse aims to advance the surgical suture, staple, and vessel sealing markets in the United States and worldwide with its unique technology.
For more information or the company's 506© investment details, visit http://www.biofusemedical.com
Media Contacts:
info@biofusemedical.com
877-466-2434
SOURCE: BioFuse Medical Technologies, Inc.
View the original press release on accesswire.com
